Posts By Alex
571Wire StoriesValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody
BETHESDA, Md. & PANGYO, South Korea–(BUSINESS WIRE)–ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, and...
- 611Wire Stories
ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody
BETHESDA, Md. & PANGYO, South Korea–(BUSINESS WIRE)–ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, and...
- 811Wire Stories
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
– Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd....
- 804Wire Stories
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
– Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd....
- 739Wire Stories
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
– Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd....
- 592Wire Stories
Asia Pacific Buy Now Pay Later Markets and Investment Opportunities Report 2022: BNPL Payments are Expected to Grow by 61.5% to Reach US$133,696.8 Million in 2022 – Forecast to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by...
- 498Wire Stories
Asia Pacific Buy Now Pay Later Markets and Investment Opportunities Report 2022: BNPL Payments are Expected to Grow by 61.5% to Reach US$133,696.8 Million in 2022 – Forecast to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by...
- 571Wire Stories
Asia Pacific Buy Now Pay Later Markets and Investment Opportunities Report 2022: BNPL Payments are Expected to Grow by 61.5% to Reach US$133,696.8 Million in 2022 – Forecast to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Buy Now Pay Later Business and Investment Opportunities – 75+ KPIs on Buy Now Pay Later Trends by...
- 593Wire Stories
Firms Fear Hybrid-Working Security Risk
30% of workers reprimanded for insecure use of collaboration tools NEW YORK–(BUSINESS WIRE)–#Questionmark–Businesses must ensure that their people keep data and systems...
- 581Wire Stories
Virgin Galactic Opens Limited Opportunity to Purchase Future Spaceflight Reservation
Launches iconic new consumer brand designed to support commercial business LAS CRUCES, N.M.–(BUSINESS WIRE)–Virgin Galactic (NYSE: SPCE) (the “Company” or “Virgin Galactic”),...
